150 Participants NeededMy employer runs this trial

Sodium + Milk Fortification for Premature Birth

(SAFE Trial)

Recruiting at 2 trial locations
JF
DN
Overseen ByDebbie Ng, MPH
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether adding sodium to the diet of very premature infants can enhance growth compared to using fortified milk alone. Researchers will compare two groups: one will receive targeted sodium supplementation (a specific increase in sodium intake) with regular testing, while the other will receive enriched milk fortification. The trial focuses on improving growth and body composition. Eligible participants are infants born very early (between 24 and 31 weeks) who are currently on full milk feeds in the NICU at the University of Washington, Oregon Health and Sciences, or the University of Cincinnati. As an unphased trial, this study provides a unique opportunity to contribute to important research that could improve the growth and development of very premature infants.

Will I have to stop taking my current medications?

The trial information does not specify whether participants must stop taking their current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Past studies on giving extra sodium to preterm infants have shown mixed results. Some research suggests it can aid weight gain and growth in the hospital. However, one study found no significant improvement in growth, such as weight and length, from sodium supplementation. Sodium can be safely administered to preterm babies with close monitoring.

Regarding milk fortification, evidence shows it is generally safe and beneficial for preterm infants. Adding nutrients to human milk has been linked to lower death rates and fewer serious health issues. However, some studies warn that early fortification might increase the risk of digestive problems, such as difficulty tolerating feeds.

Both treatments have undergone safety studies. Sodium supplementation may offer benefits if carefully managed, and milk fortification is generally considered safe and effective.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for premature birth because they offer a tailored approach to nutritional support. The targeted sodium supplementation method stands out by using regular sodium testing to customize sodium intake based on each infant's needs, potentially improving growth outcomes more effectively than standard methods. On the other hand, enriched milk fortification ensures that milk is fortified according to growth metrics, providing a more personalized nutrition plan. These strategies aim to optimize the nutritional intake for premature infants, which could lead to better overall health and development.

What evidence suggests that this trial's treatments could be effective for improving growth and body composition in very preterm infants?

This trial will compare targeted sodium supplementation with enriched milk fortification for premature birth. Research has shown that early sodium supplements can help preterm babies gain weight and grow better. Adjusting sodium levels based on urine tests may further accelerate growth. One study found that preterm babies receiving sodium supplements gained weight and grew in length more effectively. However, another study found that sodium supplements did not consistently improve growth in very preterm babies. Despite mixed results, the potential benefits of targeted sodium supplements for growth in premature babies remain promising.678910

Who Is on the Research Team?

KS

Katie Strobel, MD, MSCR

Principal Investigator

University of Washington

Are You a Good Fit for This Trial?

This trial is for very premature infants (born between 24 and almost 32 weeks) who are in the NICU at certain hospitals, are about two weeks old, and can tolerate full feedings. Babies with serious kidney issues, gut problems, genetic conditions affecting growth, or a short expected hospital stay can't join.

Inclusion Criteria

Admitted to the University of Washington, Oregon Health and Sciences, or University of Cincinnati NICU at 14 days of age
I am able to get all my nutrition by eating or tube feeding.
I was born between 24 and 31 weeks of pregnancy.

Exclusion Criteria

Anticipated NICU stay less than 30 days
Enrollment in a concurrent interventional study that may confound study outcomes
I was born with a genetic condition that affects my growth.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Targeted sodium supplementation and milk fortification from day of life 14 through 36 weeks postmenstrual age, with tapering through 38 weeks PMA

22-24 weeks
Bi-weekly visits for serum and urine sodium testing

Follow-up

Participants are monitored for safety and effectiveness after treatment, including body composition assessments

4-10 weeks
Weekly assessments during hospitalization

Open-label extension (optional)

Participants may continue to receive sodium supplementation based on clinical need

What Are the Treatments Tested in This Trial?

Interventions

  • Milk Fortification
  • Targeted Sodium Supplementation

Trial Overview

The study compares two ways to help preterm babies grow: one group gets sodium supplements based on regular blood and urine tests; the other group receives standard milk fortification with only blood sodium checks. The goal is to see which method better supports healthy growth.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Targeted sodium supplementationExperimental Treatment3 Interventions
Group II: Enriched Milk FortificationActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

Citations

The Changing Landscape of Sodium Needs in the Preterm ...

The authors concluded that early postnatal sodium supplementation significantly enhances in-hospital weight and linear growth, with untreated ...

Sodium Supplementation Algorithm to Promote Growth in ...

Using urine sodium concentration to guide sodium supplementation in preterm infants 250/7 to 296/7 weeks gestational age may promote more rapid ...

Sodium and Growth in Preterm Infants: A Review - PMC - NIH

This article is intended to review the relationship between sodium homeostasis and growth, outline reasons why preterm infants may become sodium deficient,

Higher versus lower sodium intake for preterm infants

Higher sodium intake may also reduce postnatal growth failure of premature babies. However, we are uncertain if there are any effects on death, ...

Impact of Early Sodium Supplementation on Hyponatremia ...

Several studies have reported improved weight gain in preterm infants given 3-5 mEq/kg/d sodium supplements initiated as early as the fourth day of life and ...

Fortification of Human Milk for Preterm Infants - PMC - NIH

Human Milk as the Best Feeding Option for Preterm Infants. Evidence-based data show that HM is the best nutritional and normative standard for infant nutrition ...

Effect of Multi-Nutrient Milk Fortification on Preterm ...

There was no significant difference in raw or adjusted neurodevelopmental (BSID scores) and motor outcomes measured between 22 and 26 months.

Human milk-based fortifiers cut mortality rate by 50% in ...

Human milk-based fortifiers cut mortality rate by 50% in preterm infants, independent study shows · Lower mortality and morbidity · Reduced ...

Effect of human milk-based fortification in extremely ...

Mortality and severe morbidity remain high in extremely preterm infants. Human milk-based nutrient fortifiers may prevent serious complications and death. We ...

Early Human Milk Fortification in Infants Born Extremely ...

Observational studies have also reported that FFM gains may lower the risk of long-term complications such as neurodevelopmental impairment,8 ...